Kyle Gano, Chief Executive Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 1,960 shares at $118.39 ($232K) on 2025-02-10, disclosed to the SEC on 2025-02-12.
Scheduled sale ($232k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $118.39 | 980 | $116K | 50.0% |
| 2 | $118.39 | 980 | $116K | 50.0% |
| Total | $118.39 avg | 1,960 | $232K | 100% |
| Filing → |
| NBIX | SELL | 2025-02-14 | $598K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $471K | — | Filing → |
| NBIX | SELL | 2025-01-17 | $9.2M | — | Filing → |